Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SurgiChip is a medical device company that developed a patented surgical site marking system designed to prevent wrong-site, wrong-procedure, and wrong-patient surgeries. The system utilizes an encoded chip or smart tag that is programmed with specific patient and procedure information and then adhered to the patient's skin at the intended surgical site. This information is verified by the surgical team using a reader during the mandatory 'time-out' protocol before an incision is made. The technology was developed to enhance patient safety and provide an automated alternative to manual skin marking. The company's technology and assets were acquired by DeRoyal Industries to be integrated into their surgical safety product line.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SurgiChip.